Torsten Hoffmann, a former executive of Roche, has been appointed chief scientific officer and executive vice president at Zealand Pharma A/S, effective 1 October 2013. In his new role, he will have overall responsibility for the company’s research and development activities. At Roche, Dr Hoffmann was head of discovery chemistry in the pharma research division at the company’s headquarters in Basel.
Zealand Pharma announced the appointment on 3 September 2013.
Copyright 2013 Evernow Publishing Ltd